Sign in

CIK 0001062822

  • Non-accelerated filer
  • Smaller reporting company

LEXICON PHARMACEUTICALS, INC.

Sign in to watch
Ticker
LXRX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
760474169
Phone
+1 281-863-3000
Business address
2445 TECHNOLOGY FOREST BLVD., SUITE 1100, THE WOODLANDS, TX, 77381
Former names
LEXICON PHARMACEUTICALS, INC./DE, LEXICON GENETICS INC/TX
Open-market buys, last 90 days
$49,999
in 1 filing
Open-market sales, last 90 days
$0
in 0 filings

Net +$49,999. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Exton Michael +$50K Chief Executive Officer 1 filing

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2022-04-30 NIES ALAN S Director Exercise or conversion · Restricted Stock Units −4,024 0
2022-04-30 LEFKOWITZ ROBERT J MD Director Exercise or conversion +4,024 31,030
2022-04-30 LEFKOWITZ ROBERT J MD Director Exercise or conversion · Restricted Stock Units −4,024 0
2022-04-30 DEBBANE RAYMOND Director Exercise or conversion +4,024 331,545
2022-04-30 DEBBANE RAYMOND Director Exercise or conversion · Restricted Stock Units −4,024 0
2022-04-30 BARKER SAM L Director Exercise or conversion +4,024 70,315
2022-04-30 BARKER SAM L Director Exercise or conversion · Restricted Stock Units −4,024 0
2022-04-30 Amouyal Philippe Director Exercise or conversion +4,024 31,030
2022-04-30 Amouyal Philippe Director Exercise or conversion · Restricted Stock Units −4,024 0
2022-02-28 Alexander Kristen VP, Finance and Accounting Exercise or conversion +3,200 12,200
2022-02-28 Alexander Kristen VP, Finance and Accounting Exercise or conversion +5,400 17,600
2022-02-28 Alexander Kristen VP, Finance and Accounting Exercise or conversion +2,700 20,300
2022-02-28 Alexander Kristen VP, Finance and Accounting Shares withheld for taxes −3,337 $2.85 $10K 16,963
2022-02-28 Alexander Kristen VP, Finance and Accounting Exercise or conversion · Restricted Stock Units −3,200 0
2022-02-28 Alexander Kristen VP, Finance and Accounting Exercise or conversion · Restricted Stock Units −5,400 5,400
2022-02-28 Alexander Kristen VP, Finance and Accounting Exercise or conversion · Restricted Stock Units −2,700 5,400
2022-02-28 Seth Kiernan VP, Chief Commercial Officer Exercise or conversion +10,007 10,007
2022-02-28 Seth Kiernan VP, Chief Commercial Officer Exercise or conversion +14,834 24,841
2022-02-28 Seth Kiernan VP, Chief Commercial Officer Exercise or conversion +5,287 30,128
2022-02-28 Seth Kiernan VP, Chief Commercial Officer Shares withheld for taxes −8,261 $2.85 $24K 21,867

Page 23 of 27 · 540 trades